Linda R. Duska on the Foundation for Women's Cancer

The FDA approval of the first poly (adenosine diphosphate-ribose) polymerase, or PARP, inhibitor in the 2010s has drastically changed how patients with gynecologic cancers are treated.

We want to be sure to ask the right questions and communicate our biggest concerns properly to our doctor, but how do we do this?

Be sure to share with us a picture of yourself sporting your swag-boxes as we gear up for Move4Her event on Sept. 26!

With growing concern over the highly contagious strain, the Foundation for Women’s Cancer asked Neil Finkler, MD, to break down how the Delta variant is dangerous for patients with cancer and whether they should get the COVID-19 vaccine.

Their endorsement of mandatory COVID-19 vaccination for health care workers aims to protect the safety of patients and residents of long-term care facilities and make the health care sector a leader in COVID-19 vaccination just as cases, hospitalizations and deaths are once again rising throughout the United States.